Zechmeister-Koss, I. and Rothschedl, E. (2015): Fully bioresorbable scaffolds for coronary artery disease. Decision Support Document 81.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
Coronary artery disease (CAD), a manifestation of atherosclerosis of the coronary arteries, belongs to the most prevalent diseases and is the leading cause of death in Austria.
Different revascularisation techniques have been developed to restore blood flow. The most recent developments in stent technology are fully bioresorbable vascular scaffolds (BVS), designed to slowly disintegrate over time. To date, two products (ABSORB®, DESolve®) have received a CE-mark.
The current evidence is not sufficient to prove that the BVS is more, or at least equally effective and safer than current revascularisation technologies. Therefore, the inclusion in the Austrian catalogue of benefits is currently not recommended. We suggest a re-evaluation in 2018.
|Item Type:||Decision Support Document|
|Keywords:||coronary artery disease (CAD), atherosclerosis bioresorbable vascular scaffold (BVS), revascularisation, stents|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
WO Surgery > WO 500-517 Operative surgical procedures. Techniques
WG Cardiovascular system
|Series Name:||Decision Support Document 81|
|Deposited on:||15 Jul 2015 13:48|
|Last Modified:||15 Mar 2016 13:15|
Repository Staff Only: item control page